HKEX IPO Calendar — Hong Kong New Listings Tracker

Track upcoming and recent Hong Kong IPOs from HKEX. Get listing dates, offer prices, sponsors, sectors — straight from the source.

Who is this for?

If you fit one of these, this actor was built for you:

• IPO investors and retail allocators trying to decide whether to subscribe to the next Mixue Bingcheng or Laopu Gold before the books close. Most HK IPOs spend just 4-5 business days in the public-offer window — by the time a deal is in Bloomberg or Reuters headlines, the retail tranche is already closing.
• Hedge funds and family offices running Asia long/short books who need to know when CATL, Hengrui, Chery Auto or WeRide are pricing so they can position related names (CATL competitors, A-share parents, EV battery supply chain) ahead of the float.
• Sector analysts building "HK biotech 18A class of 2026" or "Chapter 18C Specialist Technology Companies" cohort studies — every listing tagged with its regulatory chapter (18A / 18C / 8A), sponsor, cornerstone book, and post-listing return.
• Financial journalists and equity-research desks writing the deal sheet, the league tables (CICC vs Goldman vs Morgan Stanley vs Huatai), or the "biggest cornerstone investor" story.
• Allocators in Hillhouse / Boyu / GIC / OrbiMed-class funds scanning the cornerstone-investor list to see which peers are anchoring which deals.

If you've ever paid Bloomberg HK IPO, Renaissance Capital or Refinitiv USD 2,000+/seat/month for this data, you're the target buyer. This actor exposes the same fields — IPO lifecycle, offer price, sponsor syndicate, cornerstone book, first-day pop, current return — via clean JSON, billed per IPO row.

What's in the box

Every Hong Kong Stock Exchange (HKEX) Main Board and GEM new listing from filing through pricing, listing day, post-IPO trading and (where applicable) withdrawal. Each row includes the issuer's legal name, HKEX ticker, current lifecycle stage (Upcoming / Pricing / Trading / Withdrawn / Postponed), listing board (Main Board / GEM), regulatory Chapter (18A for pre-revenue biotech, 18C for Specialist Technology Companies, 8A for Weighted Voting Rights, or null for standard listings), GICS-style sector, plain-English business description, filing / priced / listing dates, offer price in HKD, indicative price range, shares offered, gross proceeds, post-money valuation, full sponsor and joint global coordinator (JGC) syndicate, cornerstone-investor list, prospectus URL on HKEXnews, first-day pop, current price, current market cap, and total return from IPO.

Plain-English glossary

A few HK-specific terms decoded for non-Hong-Kong-IPO people:

• Sponsor — the HKEX-sanctioned bank legally responsible for the listing. Every HK IPO must have at least one sponsor (often two or three for big deals). Examples: CICC, Goldman Sachs, Morgan Stanley, Huatai International, CITIC Securities, China Securities, JP Morgan, UBS, Bank of America, China Renaissance.
• Joint Global Coordinator (JGC) — the wider syndicate of banks running the bookbuild. The JGC list is usually a superset of the sponsor list (sponsors plus additional bookrunners). League tables are typically scored on JGC roles.
• Cornerstone investor — a pre-committed buyer who anchors the deal before the book opens, typically taking 30-60% of the Main Board offer size with a 6-month lock-up. In HK, the cornerstone book is one of the highest-signal datapoints in capital markets — names like Hillhouse Capital, GIC Singapore, Boyu Capital, Sequoia China, OrbiMed, BlackRock, Invesco, Schroders, China Investment Corporation and Kuwait Investment Authority show up repeatedly.
• Application Proof / PHIP — the prospectus stages on HKEXnews. Application Proof (A1) is the first public filing; Post-Hearing Information Pack (PHIP) comes after the HKEX listing committee hearing and is the near-final prospectus.
• Chapter 8A — the Weighted Voting Rights framework (2018), enabling dual-class share structures for "innovative companies." Xiaomi, Meituan, Alibaba's HK secondary, JD.com's HK secondary, NetEase's HK secondary, Bilibili and Trip.com all listed under 8A.
• Chapter 18A — pre-revenue biotech listings (2018), allowing companies with no commercial product to list if they meet specific R&D milestones. InnoCare, BeiGene, Innovent, Cansino, RemeGen, Hutchmed are the original 18A wave; Duality Biotherapeutics and Hansoh Pharmaceutical Innovation are the current 2025-2026 vintage.
• Chapter 18C — Specialist Technology Companies (2023), opened HK to pre-revenue AI / semiconductor / advanced-manufacturing names. QuickPass was the first 18C listing; Black Sesame (auto AI chips) and Plus AI (autonomous trucking) followed. WeRide is on the forward 2026 calendar under 18C.
• A+H secondary — a mainland-China A-share-listed company doing a Hong Kong secondary listing. The 2024-2026 wave includes Midea Group (the HK$31bn deal that reopened the A+H pipeline), S.F. Holding, CATL (forward), Hengrui Pharmaceuticals (forward), and Seres Group (forward).
• First-day pop — the percentage change between the offer price and the first-day close. Negative numbers mean the deal "broke" on debut (Black Sesame -27%, Chabaidao -27%, QuickPass -27% — defining IPO duds of the cycle). Positive numbers mean the deal popped (Laopu Gold +71%, Mixue Bingcheng +43%, Duality Bio +117%).

Concrete worked examples

Example 1 — "I want every HK IPO that priced in the last 90 days."

{ "mode": "recent", "lookbackDays": 90, "limit": 50 }

Returns ~10-15 rows covering the Q1-Q2 2026 vintage (Mixue Bingcheng, Hua Hong Semi placement, Plus AI under Chapter 18C, Cao Cao Mobility, etc.) with full pricing, sponsor lists, cornerstone books and current return.

HKEX has been the world's #1 IPO venue by proceeds in 5 of the last 15 years (2009, 2010, 2011, 2012, 2018) and ranks consistently in the global top 3. The HK IPO universe is unique: ~30-100 IPOs per year split across mainland-China A+H secondary listings (Midea Group HK$31bn, S.F. Holding HK$5.7bn, CATL forward, Hengrui forward), Chapter 18A pre-revenue biotech (Duality Bio, Hansoh Pharmaceutical Innovation), Chapter 18C Specialist Technology Companies (Black Sesame, Plus AI, QuickPass), Chapter 8A weighted-voting-rights tech (Alibaba secondary, Xiaomi, Meituan), and the resurgent 2024-2026 China consumer brand wave (Mixue Bingcheng, Chabaidao, Laopu Gold, China Resources Beverage). Cornerstone investors typically pre-place 30-60% of Main Board offer size, making the cornerstone book one of the highest-signal datapoints in Asian capital markets.

This actor is part of the NexGenData Apify fleet — HK-specific data anchors a high-value institutional slice of NexGenData traffic. Sources are curated from HKEX listing-committee hearing schedules, HKEXnews prospectus registry, sponsor PHIPs (Post-Hearing Information Packs), South China Morning Post / Hong Kong Economic Journal IPO coverage, and cornerstone-investor press releases.

---

What you get per row

Each dataset row is a single HKEX IPO event:

• company_name — issuer legal name (e.g. Mixue Bingcheng, Midea Group — H Shares, Horizon Robotics, Laopu Gold, Black Sesame International)
• ticker_symbol — HKEX ticker code (e.g. 2097.HK for Mixue, 0300.HK for Midea H, 9660.HK for Horizon Robotics, 6181.HK for Laopu Gold)
• listing_status — Upcoming, Pricing, Trading, Withdrawn, or Postponed
• listing_board — Main Board or GEM
• chapter — 18A (pre-revenue biotech), 18C (Specialist Technology Companies), 8A (Weighted Voting Rights) or null (standard listing)
• sector — Technology / Healthcare / Financials / Consumer Discretionary / Consumer Staples / Industrials / Energy / Real Estate / Materials / Communication Services / Utilities
• business_description — 1-3 line plain-English summary
• filing_date — date prospectus / A1 application form filed with HKEX listing committee
• ipo_date — listing (first-day-of-trading) date in ISO-8601 (YYYY-MM-DD)
• priced_date — date the offer price was finalised (typically 5-7 days before ipo_date)
• withdrawn_date — date the IPO was pulled (Withdrawn) or postponed indefinitely (Postponed)
• ipo_price_hkd — final offer price in HKD
• price_range_hkd — indicative price range from the red-herring prospectus
• shares_offered — number of new H-shares in the offering
• proceeds_hkd_million — gross proceeds raised, HKD millions
• valuation_hkd_million — post-money market cap at listing, HKD millions
• sponsors — list of HKEX-sanctioned listing sponsors (CICC, Goldman Sachs, Morgan Stanley, Huatai International, CITIC Securities, etc.)
• joint_global_coordinators — full JGC syndicate (typically larger than sponsor list — adds bookrunners)
• cornerstone_investors — list of named cornerstone investors
• prospectus_url — link to the HKEXnews prospectus filing (PDF)
• first_day_pop_pct — first-day close vs offer price (signed percentage)
• current_price_hkd — latest HKEX market price
• current_market_cap_hkd_million — current market cap, HKD millions
• gain_loss_from_ipo_pct — total return from IPO price (signed percentage)
• data_source — provenance tag

---

Quick-start example

{
  "mode": "recent",
  "lookbackDays": 30
}

Returns every HKEX IPO that started trading in the last 30 days with full pricing, sponsor list, cornerstone book and post-IPO return.

from apify_client import ApifyClient
client = ApifyClient("<YOUR_APIFY_TOKEN>")

run = client.actor("nexgendata/hkex-ipo-calendar").call(run_input={
    "mode": "both",
    "lookbackDays": 90,
    "lookaheadDays": 60,
    "listingBoard": "Main Board",
    "sector": "Technology",
    "limit": 50
})
for ipo in client.dataset(run["defaultDatasetId"]).iterate_items():
    print(ipo["company_name"], ipo["listing_status"], ipo["proceeds_hkd_million"])

curl -X POST "https://api.apify.com/v2/acts/nexgendata~hkex-ipo-calendar/runs?token=YOUR_APIFY_TOKEN" \
  -H 'Content-Type: application/json' \
  -d '{"mode":"upcoming","lookaheadDays":60,"limit":25}'

---

Inputs

• mode — upcoming / recent / both (default)
• lookbackDays — past N days of completed HKEX IPOs (1-1825, default 30)
• lookaheadDays — forward N days of pipeline (1-365, default 30)
• listingBoard — all / Main Board / GEM
• sector — all / Technology / Healthcare / Financials / Consumer Discretionary / Consumer Staples / Industrials / Energy / Real Estate / Materials / Communication Services / Utilities
• minProceedsHkdMillion — proceeds floor in HKD millions (e.g. 1000 for HK$1bn+ deals only)
• limit — 1-200 records returned

---

Output sample (Mixue Bingcheng, the defining 2026 HK consumer IPO)

{
  "company_name": "Mixue Bingcheng (蜜雪冰城)",
  "ticker_symbol": "2097.HK",
  "listing_status": "Trading",
  "listing_board": "Main Board",
  "chapter": null,
  "sector": "Consumer Staples",
  "business_description": "World's largest F&B chain by store count (45,000+ stores, larger than McDonald's globally)...",
  "filing_date": "2025-01-02",
  "ipo_date": "2026-03-03",
  "priced_date": "2026-02-25",
  "ipo_price_hkd": 202.50,
  "price_range_hkd": "182.00 - 202.50",
  "shares_offered": 17059900,
  "proceeds_hkd_million": 3454.6,
  "valuation_hkd_million": 76400.0,
  "sponsors": ["Bank of America", "Goldman Sachs", "UBS"],
  "joint_global_coordinators": ["Bank of America", "Goldman Sachs", "UBS", "Morgan Stanley"],
  "cornerstone_investors": [
    "Hillhouse Capital", "Boyu Capital", "M&G Investments",
    "Schroder Investment Management", "Singapore GIC"
  ],
  "prospectus_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0225/2026022500412.pdf",
  "first_day_pop_pct": 43.2,
  "current_price_hkd": 462.40,
  "current_market_cap_hkd_million": 174300.0,
  "gain_loss_from_ipo_pct": 128.3
}

---

8 use cases

1. Forward HK IPO calendar for buy-side allocators — {"mode":"upcoming","lookaheadDays":90} returns the active book-build pipeline with offer-price range, sponsor syndicate and pre-launched cornerstone book. Use to size primary-allocation pitches, stagger fund deployment across the calendar, and front-run sell-side IPO Day 1 calls.

2. A+H secondary-listing intel for mainland-China fund PMs — Filter sector="Technology" or sector="Industrials" and watch for company_name ending in "— H Shares". The 2024-2026 wave (Midea Group, S.F. Holding, CATL, Hengrui, Seres) is the largest A+H pipeline since 2017 and a critical Stock Connect southbound flow driver.

3. Chapter 18A pre-revenue biotech monitoring — Filter by chapter="18A" (e.g. Duality Bio, Hansoh Pharmaceutical Innovation) to track the post-2022-biotech-winter recovery. 18A names dominate HKEX biotech IPO supply and are essential cohort signal for healthcare investors.

4. Chapter 18C Specialist Technology Companies wave tracking — Filter by chapter="18C" to track the 2023-onwards regime: QuickPass, Black Sesame, Plus AI, WeRide forward. 18C is HK's answer to Nasdaq's pre-revenue-tech listings — central to the HKEX tech-IPO revival.

5. Cornerstone-investor flow mapping — Scan cornerstone_investors across 2024-2026 Main Board deals to map which sovereign / asset-manager (GIC Singapore, Hillhouse Capital, Boyu Capital, Norges Bank, Kuwait Investment Authority, OrbiMed, BlackRock, Schroders) is putting cornerstone tickets on HK IPOs. Highest-signal datapoint in Asian capital markets.

6. Sponsor / JGC league-table analysis — Count appearances in sponsors and joint_global_coordinators to size CICC vs Goldman Sachs vs Morgan Stanley vs Huatai International vs CITIC Securities vs China Renaissance market share on HKEX. Critical for sell-side ECM ranking and DCM client pitching.

7. Post-IPO return cohort study — first_day_pop_pct and gain_loss_from_ipo_pct let quants and family offices build HK-IPO vintage performance studies. The 2024-2026 cohort split is dramatic — Mixue +128%, Laopu Gold +1937%, Horizon Robotics +109% versus Black Sesame -42%, Chabaidao -46%, QuickPass -70%. Use to feed mean-reversion / momentum models on Day 91+.

8. Withdrawn-deal market-tone gauge — Filter by listing_status="Withdrawn" or "Postponed" (Bawang Chaji 2024 switched HK→Nasdaq, Saudi Aramco HK secondary shelved 2023) — a leading indicator of choppy HK primary-market sentiment that institutional desks need but is buried in HKEXnews PDFs.

---

How this compares to commercial HK IPO alternatives

Source	Coverage	Cost	Latency	API access	Notes
Bloomberg Terminal (HK IPO, EQS NI)	Global IPO calendar incl. HKEX	USD ~2,400 / seat / month	Real-time	BPIPE	Best in class. Seat cost prohibitive for HK-only research; structured-data export still requires Bloomberg Enterprise Data License.
Renaissance Capital IPO Intelligence	Global IPO + ETFs	USD ~10,000+ / year (institutional)	Same-day	Limited API	Strong on US, thin on HK — HKEX deals appear later than local sources.
Refinitiv Eikon / LSEG Workspace (IFR Asia)	Global league tables + HK deals	USD ~1,800-2,200 / seat / month	Real-time	LSEG Datastream	Strong league-table data; no flat per-record pricing.
FT IPO Tracker / Financial Times Markets	US + EU coverage	Subsumed in FT subscription	Editorial	None	HK coverage is editorial / event-driven; not a structured dataset.
HKEX official website (hkex.com.hk)	Listing-committee hearing schedule	Free	Filing-day	None (JS-rendered)	Authoritative but unscrapable at scale; PDF-heavy; no consolidated history.
HKEXnews (www1.hkexnews.hk)	Every prospectus filed with HKEX	Free	Filing-day	Search UI only	Source of truth for offering terms — but PDF-only, no structured API.
South China Morning Post + Hong Kong Economic Journal	Editorial coverage	USD ~120-220 / year subscription	Same-day	None	Strong narrative + cornerstone reporting; no machine-readable export.
This actor (nexgendata/hkex-ipo-calendar)	Main Board + GEM, 2024+ + forward calendar + selected mega-history	Per-record pricing	Per-version refresh	REST + Apify SDK + MCP	Flat per-record HK IPO institutional intel; no seat cost; clean schema; ideal for HK-focused desks, family offices, fintechs.

A typical 25-record run is orders of magnitude below a single seat-month of Bloomberg or Refinitiv — but with the same primary-market ground-truth (HKEXnews prospectus URLs, sponsor names, cornerstone books). Mainland-China hedge funds, family offices, fintech KYC stacks and HK-focused regional research desks get exactly the HK IPO data they need without paying for global coverage they don't.

---

Coverage

• Main Board IPOs: every major Main Board IPO from 2024-01 onwards (Midea Group, S.F. Holding, Horizon Robotics, Chabaidao, China Resources Beverage, Laopu Gold, Mixue Bingcheng, Cao Cao) plus the 2026 forward calendar (CATL, Hengrui, WeRide secondary, Chery Automobile, Seres Group).
• Chapter 18A pre-revenue biotech: Duality Biotherapeutics, Hansoh Pharmaceutical Innovation, and the ongoing 18A pipeline.
• Chapter 18C Specialist Technology Companies: QuickPass (first 18C listing), Black Sesame International, Plus AI — the defining 18C-regime case studies.
• A+H secondary listings: Midea Group, S.F. Holding, Hua Hong Semiconductor, plus the 2026 forward CATL / Hengrui / Seres pipeline — the largest A+H wave since 2017.
• GEM: relaunched 2024 with revised rules — coverage expanding.
• Withdrawn / Postponed: Bawang Chaji 2024 (switched HK→Nasdaq), Saudi Aramco HK secondary (shelved 2023) — central to HK market-tone analysis.
• Historical mega-deals: Alibaba 2019 secondary (Chapter 8A pioneer) retained as reference row.

Data refresh: per-version updates align to the HKEX listing-committee hearing schedule + HKEXnews prospectus drops + cornerstone-investor press-release timing.

---

FAQ

Q: How does this differ from your IPO Tracker (US) actor? A: IPO Tracker covers the NYSE + Nasdaq US primary market with SEC S-1 metadata. This actor covers HKEX (Main Board + GEM) — different sponsors (CICC vs Goldman Sachs/Morgan Stanley), different cornerstone-book mechanics (HK Mainboard offers are 30-60% pre-cornerstoned vs ~5-15% on US listings), different chapters (18A/18C/8A — no US equivalent), HKD-denominated pricing, and the China A+H secondary-listing wave that has no direct US analog. Use both side-by-side if you cover both markets.

Q: How does it differ from your SGX IPO Calendar (Singapore)? A: SGX IPO Calendar covers the Singapore Exchange (Mainboard + Catalist) — a smaller, REIT-dominated primary market (~5-30 IPOs/year). HKEX is 3-10x larger by IPO count, dominated by mainland-China issuers, and has distinct chapter regimes (18A/18C/8A). The two datasets are complementary for Asian institutional desks covering both venues.

Q: Is the data scraped live from HKEXnews on every run? A: No — HKEX listing-committee hearing schedules and prospectuses live in JS-rendered pages and PDFs that don't have a public structured API. The dataset is curated and hand-verified from HKEXnews + sponsor PHIPs + HK Economic Journal + South China Morning Post coverage, then refreshed at the version level. This matches what Bloomberg HK IPO and Renaissance Capital do operationally — they curate too, then layer pricing on top.

Q: What's a Chapter 18A / 18C / 8A listing? A: HKEX has three special listing regimes:

• Chapter 18A (2018) — pre-revenue biotech listings (e.g. Duality Bio, Innovent, BeiGene). Requires HK$1.5bn+ market cap, a Phase II+ asset, and sophisticated-investor backing.
• Chapter 18C (2023) — pre-revenue Specialist Technology Companies (AI, semis, advanced manufacturing). Used by QuickPass, Black Sesame, Plus AI. Requires R&D spend + revenue track / sophisticated-investor backing.
• Chapter 8A (2018) — Weighted Voting Rights structures for "innovative companies". Used by Xiaomi, Meituan, Alibaba secondary, JD.com secondary, NetEase secondary, Bilibili. Founders retain 10:1 voting rights.

Q: How current is the forward calendar? A: Anchored to the HKEX listing-committee hearing schedule + sponsor PHIPs as of the latest version refresh. Deals with filed A1 forms and PHIP submissions appear; rumored / sponsor-mandated deals do not until they file. Refresh cadence matches the HKEX hearing schedule.

Q: Why per-record pricing instead of per-call? A: HK IPO data is institutional intel — a single forward-calendar deal (e.g. CATL H Shares HK$36bn) can drive a single allocation worth tens of millions to a fund. Per-record pricing aligns cost to value: smoke a 5-IPO recent pull cheaply; pull the full HK pipeline + historical when you actually need it for a pitch or quant study.

Q: Can I plug this into Zapier / Make.com / n8n / LangChain agents? A: Yes — Apify exposes the dataset via REST API and the JSON Lines output stream. The Apify Zapier integration, Make.com app and n8n node all read this actor's output. Use Apify MCP servers to wire it into Claude / GPT-4 / Gemini agents directly.

---

Companion actors in the NexGenData fleet

For end-to-end HK + APAC institutional research, pair with:

• SGX IPO Calendar (Singapore) — sister APAC IPO calendar for SGX Mainboard + Catalist
• IPO Tracker (US) — NYSE + Nasdaq IPO calendar with SEC S-1 metadata
• HKEX Hang Seng Stock Screener — post-IPO HK secondary-market fundamentals + screener
• HK Companies Registry — corporate-registry intelligence for HK-incorporated entities (directors, shareholders, filings)
• HK Centaline Property Index — Hong Kong residential property price index (Centa-City Leading Index, CCL) — track the macro wealth-effect backdrop for HK IPO demand
• HK Land Registry Transactions — Hong Kong property sales and mortgage transactions from the Land Registry — see where IPO proceeds end up

---

Get started

Sign up for Apify with the NexGenData referral and run this actor in under 60 seconds. New accounts get $5 platform credit — enough to pull the entire 2024-2026 HKEX IPO calendar twice over.

Explore the full NexGenData Apify fleet — 280+ actors and 30+ MCP servers spanning Asian equities, US equities, regulatory filings, lead-gen, real-estate, and AI-agent infrastructure.